Recently, we combined PET-CT scanning with global gene expression profiling of BM CD138-selected plasma cells (PC) from 512 newly diagnosed MM patients to show that the absence of osteolytic lesions is linked to elevated expression of cystatin M/E (CST6), a cysteine protease inhibitor, secreted by MM cells. This evidence concerns the gene SDC1 and Miyoshi myopathy.